NCT02572947View on ClinicalTrials.gov

A Pilot Study of MONOtherapy of DOlutegravir in HIV-1 Virologically Suppressed Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

September 30, 2017

Conditions
Human Immunodeficiency VirusDolutegravirMonotherapyTreatment Efficacy
Interventions
DRUG

Dolutegravir

Trial Locations (1)

1205

University Hospitals of Geneva, HIV unit, Geneva

All Listed Sponsors
lead

Calmy Alexandra

OTHER

NCT02572947 - A Pilot Study of MONOtherapy of DOlutegravir in HIV-1 Virologically Suppressed Patients | Biotech Hunter | Biotech Hunter